Choosing an iso-osmolar dimeric contrast agent can reduce the risk of damage to kidneys in patients with diabetes or impaired renal function, according to a multinational study. Researchers in 17 centers evaluated serum creatinine output for 135
Choosing an iso-osmolar dimeric contrast agent can reduce the risk of damage to kidneys in patients with diabetes or impaired renal function, according to a multinational study.
Researchers in 17 centers evaluated serum creatinine output for 135 patients with impaired kidney function in a double-blinded study of iodixanol, an iso-osmolar nonionic dimeric contrast medium, and iohexol, a low-osmolar nonionic monomeric contrast medium.
Compared with a baseline reading, patients given iodixanol had an average peak increase of 11.2 mmol/L of creatinine during the next three days. For patients given iohexol, the increase was 48.2 mmol/L. Only 3% of patients given iodixanol crossed the threshold for nephrotoxicity, compared with 26.2% for iohexol patients.
The result, according to lead author Dr. Peter Aspelin of Huddinge University Hospital in Stockholm, was that patients given iodixanol were 11 times less likely to experience nephrotoxicity. The findings of the Nephrotoxicity in High Risk Patients study were published recently in the New England Journal of Medicine and presented at the European Congress of Radiology.
"The risk of nephropathy is already high in patients with diabetes mellitus," he said. "Iodixanol can lower that risk."
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.